JP2025517442A5 - - Google Patents
Info
- Publication number
- JP2025517442A5 JP2025517442A5 JP2024568889A JP2024568889A JP2025517442A5 JP 2025517442 A5 JP2025517442 A5 JP 2025517442A5 JP 2024568889 A JP2024568889 A JP 2024568889A JP 2024568889 A JP2024568889 A JP 2024568889A JP 2025517442 A5 JP2025517442 A5 JP 2025517442A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- formula
- compound according
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10202205354V | 2022-05-20 | ||
| SG10202205354V | 2022-05-20 | ||
| PCT/SG2023/050202 WO2023224545A2 (en) | 2022-05-20 | 2023-03-28 | Tead targeting compounds and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517442A JP2025517442A (ja) | 2025-06-05 |
| JP2025517442A5 true JP2025517442A5 (https=) | 2026-03-16 |
Family
ID=88836293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024568889A Pending JP2025517442A (ja) | 2022-05-20 | 2023-03-28 | Ｔｅａｄを標的とする化合物およびその方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250197355A1 (https=) |
| EP (1) | EP4526295A4 (https=) |
| JP (1) | JP2025517442A (https=) |
| CN (1) | CN119630646A (https=) |
| WO (1) | WO2023224545A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025188239A1 (en) * | 2024-03-05 | 2025-09-12 | Agency For Science, Technology And Research | Pan-tead inhibitors and methods thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017053706A1 (en) * | 2015-09-23 | 2017-03-30 | The General Hospital Corporation | Tead transcription factor autopalmitoylation inhibitors |
| EP3866798A4 (en) * | 2018-10-15 | 2022-07-13 | Dana-Farber Cancer Institute, Inc. | ENHANCED TRANSCRIPTIONAL ASSOCIATED DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND THEIR USES |
-
2023
- 2023-03-28 US US18/867,750 patent/US20250197355A1/en active Pending
- 2023-03-28 WO PCT/SG2023/050202 patent/WO2023224545A2/en not_active Ceased
- 2023-03-28 JP JP2024568889A patent/JP2025517442A/ja active Pending
- 2023-03-28 CN CN202380054759.5A patent/CN119630646A/zh active Pending
- 2023-03-28 EP EP23808009.7A patent/EP4526295A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508103A5 (https=) | ||
| JP2022541483A5 (https=) | ||
| JP2021516231A5 (https=) | ||
| ES2660263T5 (en) | Combination of akt inhibitor compound and abiraterone for use in therapeutic treatments | |
| JP6021805B2 (ja) | 腫瘍治療剤 | |
| KR101668931B1 (ko) | 항종양제의 효과 증강제 | |
| JP2022544280A5 (https=) | ||
| JP2009534386A5 (https=) | ||
| JP2014508804A5 (https=) | ||
| JP2010532768A5 (https=) | ||
| JP2017526677A5 (https=) | ||
| CN111902417A (zh) | 一种二芳基巨环化合物、药物组合物以及其用途 | |
| JP2020097577A5 (https=) | ||
| JP2015500885A5 (https=) | ||
| JP2021504384A5 (https=) | ||
| JP2022554272A5 (https=) | ||
| JP2016540811A5 (https=) | ||
| JP2016501838A5 (https=) | ||
| JP2021524844A5 (https=) | ||
| JP2016525104A5 (https=) | ||
| JP2010506919A5 (https=) | ||
| JP2016508135A5 (https=) | ||
| JP2019526546A5 (https=) | ||
| CA2526989A1 (en) | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | |
| JP2025517442A5 (https=) |